Black Rock Inc. Gbs Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.56 - $1.31 $17,457 - $40,837	-31,174 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.43 - $1.7 $3,776 - $14,929	8,782 Added 39.22%	31,174 $24,000
Q4 2021 Feb 10, 2022	BUY	$1.26 - $2.45 $730 - $1,421	580 Added 2.66%	22,392 $32,000
Q3 2021 Nov 09, 2021	BUY	$2.26 - $4.29 $48,126 - $91,355	21,295 Added 4118.96%	21,812 $55,000
Q2 2021 Aug 11, 2021	BUY	$2.65 - $5.72 $1,370 - $2,957	517 New	517 $2,000

Ticker GBS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,889,900
Description
GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, t...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.